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Introduction
Hypokalemia is a frequent problem in peritoneal
dialysis (PD) and found in 10-36% of PD patients1).
Cellular uptake and bowel loss probably play impor-
tant roles in the pathogenesis of hypokalemia. How-
ever, ongoing losses of potassium into dialysate are
also an important contributing factor to hypokalemia.
This is compounded further by poor nutritional intake,
particularly diets including potassium-rich foods like
fruits and vegetables2). In most conditions, the plasma
potassium concentration varies directly with body
potassium stores; total body potassium is a strong
predictor of skeletal muscle mass3). It was also re-
ported that hypokalemia was associated with malnu-
trition or severe comorbidity in peritoneal dialysis
patients2). We performed this cross-sectional study to
investigate the clinical characteristics of the patients
with hypokalemia and the relationship between serum
potassium level and nutritional markers, peritoneal
transport status, dialysis adequacy, biocompatibility of
PD solution, and other clinical indices.
Materials and Methods
1. Patient selection
We studied 68 patients with end-stage renal dis-
ease (ESRD) who had received maintenance continu-
ous ambulatory peritoneal dialysis (CAPD) treatment
for at least six months. Since the peritoneal membrane
Factors associated with Hypokalemia in
Continuous Ambulatory Peritoneal Dialysis Patients
Hyun-Wook Kim, M.D., Jae Hyun Chang, M.D., Sun Young Park, M.D., Sung Jin Moon, M.D.
Dong Ki Kim, M.D., Jung Eun Lee, M.D., Seung Hyeok Han, M.D., Beum Seok Kim, M.D.
Shin-Wook Kang, M.D., Kyu Hun Choi, M.D., Ho Young Lee, M.D. and Dae-Suk Han, M.D.
Department of Internal Medicine, Yonsei University College of Medicine
The Institute of Kidney Disease, Yonsei University, Seoul, Korea
Hypokalemia is a frequent problem in patients on continuous ambulatory peritoneal dialysis (CAPD) and
is affected by multiple factors. To evaluate factors associated with hypokalemia, we studied 68 patients
on maintenance CAPD treatment for at least six months. In univariate analysis, patients with hypokalemia
were associated with older age and the presence of diabetes mellitus. Serum albumin, calcium-phosphate
product, triglyceride, body mass index, protein nitrogen appearance, and lean body mass assessed by
creatinine kinetics were significantly lower as compared to those without hypokalemia. Serum C-reac-
tive protein was significantly higher in the patients with hypokalemia. Multivariate stepwise linear
regression analysis revealed that the serum albumin level and the ultrafiltration volume at the peritoneal
equilibration test were independent factors associated with hypokalemia. This suggests that the serum
potassium level may be an important nutritional marker in CAPD patients. Further longitudinal in-
vestigation is needed to clarify this relationship.
Hypokalemia, Potassium, Continuous ambulatory peritoneal dialysis, Nutritional status
Original article
HW Kim et al. : Factors associated with Hypokalemia in Continuous Ambulatory Peritoneal Dialysis Patients
transport characteristics can affect serum potassium
level in PD patients, we only selected those subjects
who underwent the standard measurements of the
peritoneal equilibration test (PET) and dialysis ade-
quacy indices on the same day as the blood was drawn
for monthly biochemical analysis at Severance Hos-
pital from July 2006 to July 2007. Demographic data
including age, sex, duration of dialysis and the use of
low glucose degradation products (GDP) solution was
also recorded.
2. Detection of hypokalemia
In this study, serum electrolyte concentrations, in-
cluding serum potassium, are represented as the mean
values of three consecutive monthly measurements
obtained one month before and one month after the date
when the PET was performed. Hypokalemia is defined
as an average serum potassium level of less than 3.5
mEq/L. Use of medication that might affect potassium
balance, including diuretics, angiotensin- converting
enzyme inhibitors (ACEI) and angiotensin receptor
blockers (ARB) was also recorded.
3. Urea and creatinine kinetics and peritoneal
equilibration test
Lean body mass was assessed by creatinine kine-
tics (LBMcr)4). Measurements of urea kinetic variables
such as the protein equivalent of nitrogen appearance
(PNA), urea nitrogen appearance (UNA), total Kt/V,
and standardized creatinine clearance were also per-
formed. The PNA was derived from the urea genera-
tion rate using the formula proposed by Bergstrom et
al.5) and was normalized to the ideal body weight of the
patients. The PET was performed to assess peritoneal
transport characteristics as previously described6).
4. Statistical analysis
Statistical analysis was performed using SPSS for
Window software, 12.0 (SPSS Inc, Chicago, IL). Re-
sults are expressed as mean standard deviation (SD)±
unless otherwise specified. Comparisons between pa-
rameters were performed using the chi-square test,
Fisher s exact test, and Mann-Whitney’ U test. For the
analysis of the correlation between serum potassium
level and other clinical parameters, we performed Pe-
arson correlation analysis and partial correlation anal-
ysis. Subsequently, to determine the factors indepen-
dently associated with serum potassium level, step-
wise multiple linear regression analyses were per-
formed, including factors that had significant associa-
tion in univariate analysis and those generally accept-
Table 1. Clinical Characteristics of the Patients
Clinical and Demographic Characteristics
Age (years) 52.4 12.1±
Male gender (%) 37 (54.4)
Duration of dialysis (months) 46.5 47.0±
Diabetes mellitus (%) 16 (20)
Medication
ACEI, ARB (%) 44 (55.0)
Loop diuretics (%) 23 (28.8)
Sodium bicarbonate (%) 1 (1.3)
rHuEPO (%) 51 (63.8)
rHuEPO dose (U/kg/week) 93.9 39.4±
Dialysis characteristics
Low GDP solution (%) 41 (51.3)
Total daily exchange volume (mL/day) 9,036.0 1,565.1±
Ultrafiltration volume at PET (mL) 624.3 341.6±
High and high average transporter (%) 44 (64.7)
4-hour D/P creatinine 0.69 0.12±
Serum electrolytes
Sodium (mEq/L) 137.5 4.7±
Potassium (mEq/L) 4.4 0.6±
Chloride (mEq/L) 97.3 5.7±
Total CO2 (mEq/L) 27.0 2.8±
Hemoglobin (g/dL) 10.1 1.7±
Serum albumin (g/dL) 3.5 0.6±
Serum phosphorus (mg/dL) 5.1 1.5±
C-reactive protein (mg/dL) 2.04 3.21±
Total cholesterol (mg/dL) 167.8 36.2±
Weekly Kt/V 2.18 0.79±
Residual renal function (mL/min) 2.11 4.40±
PNA (g/day) 6.09 12.14±
nPNA (g/kg/day) 0.98 0.17±
Body mass index (kg/m2) 23.8 3.7±
LBMcr (kg) 42.4 10.4±
%LBM/IBW (%) 68.4 14.5±
Values are expressed as mean SD or number (%).±
ACEI angiotensin-converting enzyme inhibitors; ARB,
angiotensin receptor blockers; rHuEPO, recombinant hu-
man erythropoietin; GDP, glucose degradation product;
PET, peritoneal equilibration test; D/P creatinine, dialysate
to plasma creatinine; PNA, protein equivalent of nitrogen
appearance; nPNA, normalized PNA; LBMCr, lean body
mass assessed by creatinine kinetics, %LBM/IBW, % lean
body mass/ideal body weight.
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ed as contributing factors.
Results
1. Demographic features of subjects
The demographic and clinical characteristics of 68
subjects are listed in Table 1. The mean age was 52.3
12.1 with a range of 25 to 78 years, the male to±
female ratio was 1.2:1. The mean CAPD duration was
46.5 47.0 months. The mean serum potassium level±
was 4.4 0.6 mEq/L with a distribution ranging from±
3.23 mEq/L to 5.56 mEq/L (Fig. 1). Seven patients
(10.3%) had an average serum potassium level less
than 3.5 mEq/L. All of these patients required oral
potassium supplementation. Forty-four patients (55.0
%) received ACEI/ARBs, and 23 (28.8%) received loop
diuretics. These drugs were administered to the pa-
tients both with and without hypokalemia. However, the
use of these medications did not make any differences
between the two groups (Table 1, 2).
2. Univariate analysis of clinical and demographic
data and correlation analysis
When patients were divided into two groups based on
serum potassium level, pati nts with hypokal mia had
sig ificantly older mean ag (p=0.045) and a higher
revalence of diab tes mellitus (p=0.048). However,
ther was no difference in the frequency of low GDP
solution use (p=0.420) and recombinan human erythro
poietin (rHuEPO) use (p=0.435) (Table 2). In th pa-
tients with hypok lemia, the serum albumin lev l,
calcium-phosphate product, s rum triglyceride level,
PNA (especially, in UNA component), body mass
indices (BMI), d LBMcr (especi ly, in excretion com-
Table 2. Clinical Characteristics of Patients with and without Hypokalemia
Without Hypokalemia (n=61) With Hypokalemia (n=7) p
Clinical and demographic characteristics
Age (years) 51.4 12.3± 60.4 5.8± 0.045
Men/women 33/61 4/7 0.60
Dialysis duration (months) 44.7 46.9± 62.34 47.9± 0.358
Diabetes mellitus (%) 12 (19.7) 4 (57) 0.048
Medication
ACEI, ARB (%) 40 (65.6) 4 (57.1) 0.477
Loop diuretics (%) 21 (34.4) 2 (28.6) 0.559
Sodium bicarbonate (%) 1 (1.6) 0 (0) 0.897
rHuEPO (%) 45 (73.8) 6 (85.7) 0.435
rHuEPO dose (U/kg/week) 92.1 39.2± 109.7 42.0± 0.374
Dialysis characteristics
Low GDP solutions (%) 36 (59.0) 5 (71.4) 0.420
Total daily exchange volume (mL/day) 9,061.5 1,454.9± 8,814.3 2,474.2± 0.538
Ultrafiltration volume at PET (mL) 637.7 339.2± 507.14 366.8± 0.275
High and high average transporter (%) 38 (62.3) 6 (85.7) 0.214
4-hour D/P creatinine 0.69 0.13± 0.75 0.09± 0.143
Values are expressed as mean SD or number (%).±
ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; rHuEPO, recombinant human
erythropoietin; GDP, glucose degradation product; PET, peritoneal equilibration test; D/P creatinine, dialysate to plasma
creatinine.
Nu
mb
er
 o
f p
at
ien
ts
Serum potassium concentration (mEq/L)
0
2
4
6
8
10
12
14
16
18
20
3.00-
3.49
3.50-
3.99
4.00-
4.49
4.50-
4.99
5.00-
5.49
5.50-
5.59
Fig. 1. Distribution of patient serum potassium levels.
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ponent) were significantly lower than those without
hypokalemia (Table 3-5). The serum C-reactive pro-
tein (CRP) level was significantly higher in the patients
with hypokalemia compared to the patients without
hypokalemia (p=0.028) (Table 3). Pearson correlation
analysis showed that serum potassium correlates
Table 3. Biochemical Characteristics of the Patients
with and without Hypokalemia
Without
Hypokalemia
(n=61)
With
Hypokalemia
(n=7)
p
Serum electrolytes
Sodium (mEq/L) 137.7 4.5± 136.0 6.9± 0.753
Potassium (mEq/L) 4.5 0.5± 3.4 0.1± <0.01
Chloride (mEq/L) 97.3 5.8± 97.4 5.2± 0.681
Total CO2 (mEq/L) 26.7 2.6± 29.1 2.8± 0.067
Hemoglobin (g/dL) 10.2 1.7± 9.3 1.7± 0.155
Serum iron ( g/dL)µ 62.4 30.0± 73.7 63.4± 0.290
Transferrin saturation (%) 27.3 13.5± 33.6 14.0± 0.311
Ferritin (ng/dL) 260.9 169.8± 470.4 505.4 0.300±
Serum albumin (g/dL) 3.6 0.5± 2.8 0.4± 0.001
Serum calcium (mg/dL) 9.0 0.8± 8.8 1.2± 0.303
Serum phosphorus (mg/dL) 5.2 1.5± 4.2 0.6± 0.053
Ca P product (mg× 2/dL2) 46.9 13.4± 36.7 9.5± 0.032
C-reactive protein (mg/dL) 1.47 2.1± 7.24 6.6± 0.028
iPTH (pg/mL) 178.7 152.6± 282.7 488.3± 0.551
BUN (mg/dL) 52.7 17.3± 46.1 11.0± 0.369
Serum creatinine (mg/dL) 11.2 4.7± 8.3 2.3± 0.109
Uric acid (mg/dL) 6.3 1.1± 6.5 1.4± 0.984
Total cholesterol (mg/dL) 168.2 35.3± 164.0 46.2± 0.856
Triglyceride (mg/dL) 133.1 81.2± 82.4 32.6± 0.041
Values are expressed as mean SD.±
Ca P, calcium-phosphate product; iPHT, intract parathy× -
roid hormone; BUN, blood urea nitrogen.
Table 5. Anthropometric Parameters of the Patients
with and without Hypokalemia
Without
Hypokalemia
(n=61)
With
Hypokalemia
(n=7)
p
Height (cm) 161.9 6.7± 161.7 4.3± 0.785
Weight (kg) 63.1 10.8± 56.1 9.2± 0.063
Body mass index (kg/m2) 24.0 3.7± 21.4 2.7± 0.041
Weight/standard
body weight 1.08 0.11± 1.04 0.06± 0.414
Body surface area (m2) 1.66 0.15± 1.58 0.13± 0.108
Volume of urea
distribution by
Watson method (L) 33.9 5.3± 31.4 4.6± 0.218
LBMcr (kg) 43.3 10.3± 34.4 7.4± 0.022
Excretion (mg/day) 971.4 281.7± 749.5 948.6± 0.026
Degradation (mg/day) 268.5 128.1± 180.9 76.4± 0.071
%LBM/IBW 69.3 15.0± 61.0 6.0± 0.088
Values are expressed as mean SD.±
LBMCr, lean body mass assessed by creatinine kinetics,
%LBM/IBW, %lean body mass/ideal body weight.
Table 4. Urea Kinetic Parameters of the Patients
with and without Hypokalemia
Without
Hypokalemia
(n=61)
With
Hypokalemia
(n=7)
p
Weekly Kt/V 2.20 0.82± 2.00 0.47± 0.739
SCCr (L/week/1.73 m2) 76.53 53.3± 72.17 21.16± 0.222
RRF (mL/min) 2.20 4.61± 1.30 1.70± 0.695
UNA (g/day) 5.25 1.71± 4.06 1.35± 0.022
PNA (g/day) 57.28 12.16± 48.70 9.58± 0.024
nPNA (g/kg/day) 0.99 0.16± 0.92 0.26± 0.084
Dialysate protein losses 5.70 2.06± 5.41 1.20± 0.976
(g/day)
Values are expressed as mean SD.±
SCCr, standardized creatinine clearance; RRF, residual
renal function; UNA, urea nitrogen appearance; PNA, pro-
tein equivalent of nitrogen appearance; nPNA, normalized
PNA.
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and ultrafiltration volumes at peritoneal equilibration
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positively with ultrafiltration volume at the PET (r=
0.309, p=0.01), sodium (r=0.301, p=0.013), serum al-
bumin (r=0.31, p=0.01), serumBUN (r=0.354, p=0.03),
serum creatinine (r=0.253, p=0.038), PNA (r= 0.292,
p=0.016), UNA (r=0.292, p=0.016), and dialysate urea
nitrogen losses (r=0.263, p=0.03) (Fig. 2, 3). In contrast,
serum potassium correlates negatively with 4-hour
dialysate to plasma (D/P) creatinine (r=-0.253, p=
0.038) (Fig. 4), total CO2 (r=-0.29, p=0.16), ferritin (r=
-0.246, p=0.048), peritoneal creatinine clearance (r=
-0.256, p=0.035), and serum CRP levels (r=-0.289,
p=0.071) (Fig. 5).
3. Multivariate analysis of the factors associated with
serum potassium levels
Multivariate stepwise linear regression analysis re-
vealed that the serum potassium level was positively-
correlated with the ultrafiltration volume at the PET
(p=0.017) and serum albumin (p=0.029) after
adjusted for factors accepted to be significant; 4-hour
D/P creatinine, dialysate urea nitrogen losses, total CO2
level, dialysate creatinine clearance, dialysate pro-
tein losses, and LBMcr (Table 6).
Discussion
The occurrence of hypokalemia is strongly de-
pendent on the patient population. In otherwise heal-
thy adults not receiving any medication, less than 1%
will develop hypokalemia7). In CAPD patients, the pre-
valence of hypokalemia has been found to vary from the
10% to 36%8). It was reported that 10-15% of PD
patients required potassium supplementation for hypo-
kalemia9). In our study, the prevalence of hypokalemia
in our center was about 10%, similar to previous
studies9).
In patients on chronic dialysis, hypokalemia is in-
duced by factors affecting internal and external po-
tassium balance. The internal potassium balance in-
cludes reduced potassium uptake by cells because of
uremia, acidosis, drugs, and alterations of the profile of
hormones influencing potassium movement and it
represents the potassium redistribution between the
intracellular and the extracellular compartments. Com-
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Fig. 5. Correlation between serum potassium levels
and C-reactive protein levels.
Table 6. Stepwise Multivariate Linear Regression Ana-
lysis of Factors Significantly Associated with Serum
Potassium Levels in Patients
Variable
Unstandardized
coefficient
Standardize
d
coefficients
( )β t pB Std. Error
(Constant)
UF
Serum albumin
2.720
0.000
0.264
0.433
0.000
0.118
0.271
0.253
6.27
6
2.43
9
2.23
0
0.00
0
0.01
7
0.02
9
UF, ultrafiltration volume at the peritoneal equilibration
test.
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Fig. 4. Correlation between serum potassium levels
and 4-hour dialysate to plasma (D/P) creatinines.
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pared to hemodialysis, peritoneal dialysis patients have
a normal or even higher intracellular potassium con-
tent, especially those on CAPD. This phenomenon is
probably related to continuous glucose absorption from
the dialysis solutions and the subsequent stimulation of
intracellular uptake of potassium, mediated by insulin
release10). The external balance includes diminished or
absent renal excretion, diminished dietary intake, and
increased fractional excretion of potassium in the
feces. The mode and frequency of dialysis also
affected both internal and external potassium balance
11). Considered from a standpoint of internal potassium
redistribution, the trend of a higher frequency of hy-
pokalemia in diabetic patients in our study is explained
by the hypothesis that the insulin hormone stimulated
by hyperglycemia together with the continuous peri-
toneal glucose absorption, could promote an excess of
potassium redistribution into the intracellular com-
partment by activating N ,K -ATPase, which results
in active potassium uptake7). From the view of ex-
ternal balance, generally dialysis itself is the main
source of external loss.
In CAPD, most dialysate solutions contain no pota-
ssium and patients dialyzed with such solutions lose
25-30 mEq of potassium per day via CAPD. Because
this amount is relatively small when compared to the
normal daily uptake (70-80 mEq)9), hypokalemia sec-
ondary to low potassium ingestion usually occurs only
after an extended period of low oral potassium intake. It
was reported that serum potassium levels in PD
patients were not only associated with nutritional sta-
tus or severity of coexisting comorbid conditions, but
were also an independent prognostic indicator in PD
patients2). In accordance with this report, we also found
that hypokalemia levels were associated with poor
nutritional indicators such as lower PNA, body mass
index, LBMcr, and serum albumin level.
Protein equivalent of nitrogen appearance computed
by urea kinetic modeling is known to reflect the die-
tary protein intake5), which is closely related to dietary
potassium intake since dietary protein contains about 1
mEq of potassium per gram12). This study also re-
vealed that dialysate urea nitrogen losses were signifi-
cantly higher in the patients without hypokalemia. This
can be probably explained by the nutritional aspect,
because dialysate urea nitrogen loss is the main
component of PNA. Some high potassium foods are also
high in phosphorus; examples include corn, yogurt,
milk, and beans13). Although not reaching statistical
significance, the serum potassium level was associated
with the serum phosphate level and also significantly
associated with calcium-phosphate, indirectly
suggesting that hypokalemic patients had an overall
reduction in general oral intake.
Serum CRP is an acute-phase protein that is a
marker for underlying systemic inflammation. The
prevalence of an increased CRP and other pro-inflam-
matory cytokines (interleukin-1, interleukin-6 and
tumor necrosis factor- ) was reported to be high in⍺
dialysis and pre-dialysis patients14). It is well docu-
mented that high levels of pro-inflammatory cytokines
may cause muscle wasting by stimulating protein ca-
tabolism via the ubiquitin-proteosome pathway 15) and
by inhibiting appetite16); they are also associated with a
higher cardiovascular mortality in ESRD patients17).
Qureshi et al. showed a close relationship between CRP
and nutritional status as assessed by SGA (subjective
global assessment)18). Noh et al. reported that serum
CRP is an independent predictor of two-year patient
survival in CAPD patients19). Recently, it was reported
that malnutrition-inflammation scores including serum
albumin level, total iron binding capacity level, BMI, etc.
correlated significantly with clinical, nutritional,
inflammatory, and anthropometric parameters in PD
patients, even more strongly than SGA20). In our study,
we also found that the patients with hypokalemia had a
significantly higher CRP level; that level was negatively
related to the serum albumin level (r=-0.29, p=0.07)
(Fig. 3) and serum potassium level (r=-0.289,
p=0.071) (Fig. 5), but these two correlations were not
statistically significant. In addition, the higher levels of
ferritin in the patients with hypokalemia in our study
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might also be explained in terms of an inflammatory
marker.
The creatinine kinetic approach to lean body mass
(LBM) estimation was reported to correlate well with
other techniques for lean body mass, such as bioimpe-
dance, infrared, and anthropometric measurements4).
We found that the patients with hypokalemia had sig-
nificantly lower LBM levels than those without hypo-
kalemia and that serum potassium levels correlated
significantly with LBM levels (r=0.31, p=0.01). The
total amount of potassium in the plasma did correlate
with total body potassium in normal subjects21), and
was expected to bear close relationship to plasma po-
tassium especially when maintained for sufficient time
at steady levels 22). A decrease in total body potassium
could either reflect a diminishing cellular mass, which is
likely to be present in malnutrition, or a change in
membrane function that is common in uremia23).
The ultrafiltration volume at the PET was signi-
ficantly lower in patients with hypokalemia than those
without hypokalemia (Table 2) and showed a positive
correlation with serum potassium levels both signi-
ficantly and independently (Fig. 2; Table 6), consistent
with the significant negative correlation between se-
rum potassium level and 4-hour D/P creatinine (Fig.
4). This is explained by both the higher rate of diffu-
sive removal of potassium through the peritoneal
membrane as a solute with a low molecular weight and
the volume overload induced by the lower rate of fluid
removal resulting from early loss of osmolar gradients.
Cheng et al. also showed that there was a strong as-
sociation between fluid status and nutritional status,
and that volume overload is associated with the de-
velopment of malnutrition with inflammation. Further-
more, improved fluid status was associated with
improvement in nutritional status24). This can be inter-
preted by the hypothesis that volume overload might
lead to gastrointestinal edema with poor nutritional
status which results in bacterial and endotoxin trans-
location. This phenomena can elevate serum TNF-⍺
and other inflammatory cytokines which induce ano-
rexia by inhibiting the normal feeding response to
energy deficits25). We also showed in our study that
lower ultrafiltration volume at a PET with higher 4-
hour D/P creatinine is associated with hypokalemia,
probably reflecting volume overload with poor nutri-
tional status. We did not find any correlation between
serum potassium level and daily exchange volume or
the dialysis adequacy index Kt/V, as with a previous
study done by Szeto et al.2).
It has been well established that serum albumin level
is a strong predictor of increased risk of morbidity and
mortality in peritoneal dialysis patients26). The amount
of albumin in the body and serum albumin concentration
are determined by multiple factors including hepatic
albumin synthesis (which is influenced by dietary
protein intake), protein catabolism, and extravascular
albumin distribution27). In addition to these factors,
CAPD patients are uniquely susceptible to the adverse
effects on levels of serum albumin because of protein
losses into the peritoneal effluent. Our study showed
that the patients with hypokalemia had significantly
lower serum albumin levels than those without
hypokalemia and that the serum albumin levels
correlated significantly with serum potassium levels
(r=0.31, p=0.01), even after adjustment by 4- hour
D/P creatinine, total body water by the Watson method
and dialysate albumin losses by partial correlation
analysis (r=0.255, p=0.041). This suggests that none
of the factors-potassium loss via the peritoneum as a
small molecule or hypoalbuminemia caused by
overhydration or excessive peritoneal loss of albumin
can explain the relationship between serum albumin
and potassium levels sufficiently. Stepwise multiple
linear regression analysis also showed that serum al-
bumin levels reveal independently-significant correla-
tion with serum potassium levels ( =0.253, p=0.029),β
together with ultrafiltration volume at the PET ( =β
0.271, p=0.017) (Table 6). Higher levels of trigly-
ceride, blood urea nitrogen, and serum creatinine in the
patients without hypokalemia can also be explained by
the common association with nutritional status.
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In summary, we have shown that the patients with
hypokalemia were associated with older age, higher
CRP levels, and the presence of diabetes mellitus.
Serum albumin, calcium-phosphate product, triglyceri-
de, BMI, PNA, and LBMcr were significantly lower as
compared to those without hypokalemia. The serum
potassium level revealed significant positive correla-
tion independently with ultrafiltration volume at the
PET and serum albumin level. These results empha-
size the importance of serum potassium level as a valid
nutritional marker as well as a potential predictor of
outcome. Further long-term follow up of a larger num-
ber of patients would be needed to clarify this rela-
tionship.
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